Renovaro Biosciences
Renovaro provides an AI-powered platform to improve cancer and neurology care. It combines diagnostics, rapid drug discovery, predictive analytics, and personalized therapeutics. The approach leverages liquid biopsy, multi-omic data, CRISPR models, and phenomics to power end-to-end workflows. As a B2B SaaS company, it integrates AI, machine learning, deep learning and genomics across diagnostics, drug development, and translational medicine. Renovaro operates globally with clinics, hospitals, and research institutions.
Renovaro Biosciences
Renovaro provides an AI-powered platform to improve cancer and neurology care. It combines diagnostics, rapid drug discovery, predictive analytics, and personalized therapeutics. The approach leverages liquid biopsy, multi-omic data, CRISPR models, and phenomics to power end-to-end workflows. As a B2B SaaS company, it integrates AI, machine learning, deep learning and genomics across diagnostics, drug development, and translational medicine. Renovaro operates globally with clinics, hospitals, and research institutions.